Iatrogenic Disease
9
0
0
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (9)
A Novel Technique to Remove Iatrogenic Pulmonary Parenchymal Chest Tube (PPcT): A Retrospective Analysis From a Tertiary Care Thoracic Surgery Centre
An INtervention TO Improve MOBility of Older Hospitalized Patients
Alleviating Geriatric Inpatients' Medication-related Iatrogenesis
Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19
Adverse Events Related to Treatments Used Against Coronavirus Disease 2019
AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)
Incidence of Iatrogenic Diseases on Hospital's Emergency Consultations
Incidence and Risk Factors for Hospitalization-Associated Disability
Rationalisation of Polypharmacy by the Geriatric Consultation Team